Iridium 192 implantation of squamous cell carcinomas of the oropharynx

Am J Otolaryngol. 1989 Sep-Oct;10(5):317-21. doi: 10.1016/0196-0709(89)90106-3.

Abstract

From 1970 to 1984, 127 patients with T1 or T2 carcinomas of the oropharynx were treated with external irradiation to the primary tumor and neck nodes to a dose of 45 Gy, followed by a further 30 Gy delivered by an iridium 192 implant to the primary tumor. Patients with clinically positive nodes had either further neck irradiation using electrons or a neck dissection. Crude 5-year disease-free survival was 66% for tonsillar carcinomas, 43% for soft palate, and 51% for base of tongue. Local control was 98%, 85%, and 76%, respectively. Regional control was 97% for N0 patients and 88% for N1-3. Soft tissue ulceration occurred in 17 patients; all healed spontaneously. The high rate of local control achieved in these patients while preserving function and minimizing xerostomia supports the use of this approach.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy*
  • Carcinoma, Squamous Cell / radiotherapy*
  • Female
  • Humans
  • Iridium Radioisotopes / therapeutic use*
  • Male
  • Middle Aged
  • Palatal Neoplasms / radiotherapy*
  • Palate, Soft
  • Retrospective Studies
  • Tongue Neoplasms / radiotherapy*
  • Tonsillar Neoplasms / radiotherapy*

Substances

  • Iridium Radioisotopes